
Restaurants, diners scrambling to deal with eye-popping egg prices
When prices began to tick up toward the end of last year, Sidell hoped they'd come down by January. Then he was assured the bird flu outbreaks would abate by February and supply would return to normal. Now he's not sure how much longer it will last, or how much longer he can take it.
Get Winter Soup Club
A six-week series featuring soup recipes and cozy vibes, plus side dishes and toppings, to get us all through the winter.
Enter Email
Sign Up
'Our next big weekend is St Patrick's Day,' Sidell said. 'So we're hoping this is resolved by then.'
Advertisement
The nationwide wholesale
price for loose eggs rose to $7.74 per dozen, up about 68 percent already this year, according to
the latest data from the
Department of Agriculture. The price for loose eggs designated 'California-compliant,'
Related
:
So far, the South Street Diner has managed to avoid the same markups as other restaurants such as Waffle House,
to his customers.
But if the price hikes reach the point 'when I can't bring home a paycheck and make sure my wife is happy,' he said — price increases would have to be on the table, he said.
'We want to make sure that everybody has a reasonable price, but we want to make sure that we can make a living,' Sidell said.
It's not just sky-high prices that are squeezing breakfast eateries. As bird flu decimates flocks in California,
Pennsylvania, and the Midwest, wholesalers are reporting chronic supply shortages, forcing diners to stretch their supplies.
Advertisement
Rob Doucette, owner of Liberty Diner on the Roxbury-South Boston line, said his kitchen goes
through a case of 30 dozen eggs about every other day. But earlier this month, his regular supplier called and said the usual order of eggs wasn't available. They assured him they would let him know when the order was ready, but that call still hasn't come.
Luckily, Doucette said he managed to stop by on the supplier's restocking day. Posted in the back of the warehouse, he said, was a sign limiting purchases to five cases of 15 dozen eggs. The cases of 30 dozen, which he normally buys, were nowhere to be seen.
'I'm going to stop by again today to see if I can purchase any more,' Doucette said
last week. 'But I'm not expecting it.'
Wholesalers said they are rationing cases to make sure all of their accounts are able to receive at least part of their regular
order, with the hope of backfilling it later.
But that poses a challenge for smaller wholesalers like Shirazi Distributing, based in Newmarket Square, which turns over its warehouse inventory two to three times a week.
'We're not sitting on product, which means anything we bring in is going to be sold within the next couple of days,' said Josh Shirazi. 'So if we're getting a delivery of eggs twice a week, and we order 10 pallets and only two or three come in, that means we're running out of eggs.'
Shirazi said the fluctuations of supply and demand are 'day to day,' making it impossible
to plan ahead.
Advertisement
'We're not bracing for it to get worse — we are braced,' he said. 'We're at the mercy of what the farms will send us."
Kay Masterson, owner of Johnny's Luncheonette in Newton, orders anywhere between 15 and 20 cases of eggs a week. The diner tries to stay ahead of potential price shocks with small, incremental increases throughout the year, she said. For now, that means she hasn't had to raise prices on her 'Jordan Marsh' skillets and other egg-centric dishes.
'You want to keep your doors open for as many people as possible,' Masterson said. 'So we are price-sensitive. We try and do our best. And it's a tricky balance.'
Masterson said it would be a painful decision to hike prices dramatically, especially since many of its customers are students and seniors who don't have a lot of money to spare.
'I know some people who are in almost every day, and I know what an integral part we are in their lives,' she said. 'I never want to get to a point where they couldn't come in and enjoy their time with us.'
Sidell said he was optimistic South Street would be able to weather the price increase without passing the costs along, adding that if the pandemic taught him anything, it was that 'there's always a new curve in the restaurant business.'
Doucette said Liberty has increased the price of its breakfast items.
His customers, he said, need only go to the grocery store to know why.
'Seeing how the market has changed and the price has risen so drastically, so quickly, people kind of understand,' he said. 'We can't help it, but if we want to continue to sell eggs and get eggs, we have to change our price accordingly.'
Advertisement
But with the end of high prices nowhere in sight — according to the USDA, there is 'little chance for improvement in the near-term' — Doucette said he might have to take more serious measures.
'I don't know what the turnaround is for buying chickens and having them reproduce,' he said. 'That would be somewhere down the road. Hopefully it doesn't get to that point.'
Waitress Leighann Weston with customers at the South Street Diner in Boston. South Street Diner serves roughly 400 dozen eggs every weekend.
David L. Ryan/Globe Staff
Camilo Fonseca can be reached at
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


TechCrunch
2 minutes ago
- TechCrunch
Intel is spinning off its Network and Edge group
In Brief Intel continues to streamline its business. The company plans to spin off its Network and Edge group, which is responsible for making chips for the telecom industry, as originally reported by CRN. Intel will be an anchor investor in the standalone business and will seek outside capital. Intel was rumored to be looking for a buyer for its Network and Edge group in May. This business produced $5.8 billion in revenue in 2024. This strategy seems similar to the company's decision to spin off RealSense, its former stereoscopic imaging technology business, earlier this month. Intel decided to spin RealSense out during former CEO Pat Gelsinger's tenure and the company struck out on its own with $50 million in venture funding. TechCrunch reached out for more information about its plans and timeline for the spinout.
Yahoo
31 minutes ago
- Yahoo
Paramount Global says Skydance merger should close in two weeks
(Reuters) -Paramount Global said on Friday it expects to complete its merger with Skydance Media by August 7, following government approval for the $8.4 billion deal. Skydance CEO David Ellison is prepared to assume the helm at Paramount, home to the venerable Paramount Pictures, the CBS broadcast network, and a collection of cable television channels. The new chief executive already is confronted with questions from investors about the future of the Paramount+ streaming service, plans for Paramount's declining television assets, and forecasts for spending on content -- including professional sports. "Now that the long, drawn-out sale process is finally nearing its end, Skydance leadership is poised to take control," wrote MoffettNathanson media analyst Robert Fishman. "With that, the real work begins -- rebuilding Paramount, addressing the critical strategic questions ahead, and charting a path toward a more sustainable and competitive future." Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
31 minutes ago
- Yahoo
Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025
SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. ('Calidi' or the 'Company') (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease, announced today that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-12 (the 'Reverse Stock Split'). The Company's common stock is expected to commence trading on a split-adjusted basis when the NYSE American market opens on August 5, 2025 under the existing symbol of 'CLDI.' The new CUSIP number for the Company's common stock following the Reverse Stock Split will be 320703 408. The noncompulsory decision to implement this stock split reflects the Company's aim to optimize market dynamics, broaden investor appeal and accessibility, and align the stock's trading conditions with the best interests of its investors. The Reverse Stock Split was approved by the Company's stockholders at its annual general meeting of stockholders held on July 9, 2025. On July 11, 2025, the Company's Board of Directors approved the Reverse Stock Split at the ratio of 1-for-12. Following the effectiveness of the Reverse Stock Split, every twelve (12) pre-split shares of outstanding common stock will become one (1) share of common stock. Stockholders of record who would otherwise be entitled to receive a fractional share will automatically be entitled to the rounding up of the fractional share to the nearest whole share. The Company does not intend to round up fractional shares at the beneficial level and will instead round any such fractional shares up at the participant level. Proportionate adjustments will be made to (i) shares of common stock issuable upon exercise or conversion of all issued and outstanding options, warrants and convertible securities of every kind, in accordance with the terms of each instrument, and (ii) shares outstanding and authorized for issuance under the Company's equity incentive plan and the employee stock purchase plan, both as amended. The Reverse Stock Split will not affect the par value of the common stock, nor the number of authorized but unissued shares of common stock, nor the Company's authorized preferred stock. Information for Calidi Stockholders Upon the effectiveness of the Reverse Stock Split, every twelve (12) shares of common stock owned prior to the split will be consolidated and reclassified into one (1) share of common stock. The Company has appointed Equiniti Trust Company, LLC as the exchange agent to facilitate the Reverse Stock Split process. Registered stockholders with shares held in book-entry form do not need to take any action to receive post-split shares. Those holding shares through brokerage accounts or 'in street name' will see their holdings automatically adjusted to reflect the Reverse Stock Split, in line with individual broker processes, without needing to take further action. Stockholders with shares in certificate form will receive instructions from Equiniti on the procedure for exchanging their certificates, as applicable, shortly after the effective date of the Reverse Stock Split. About Calidi Biotherapeutics Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage biotechnology company pioneering the development of targeted therapies that can deliver genetic medicines to sites of disease. The company's proprietary Redtail platform represents a decade of development and expertise in designing viral vectors that can evade immune detection allowing for systemic delivery and distal sites of disease in oncology and, potentially, other indications. This advanced enveloped technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent gene therapies to metastatic locations. The lead candidate from the Redtail platform, currently in IND-enabling studies, targets non-small cell lung cancer, ovarian cancer, and other tumor types with high unmet medical need. Additionally, Calidi is developing protected virotherapies, in clinical-stage, for intratumoral and localized administration, focusing on a subset of injectable cancer indications. Calidi Biotherapeutics is headquartered in San Diego, California. For more information, please visit Forward-Looking StatementsThis press release may contain forward-looking statements for purposes of the 'safe harbor' provisions under the United States Private Securities Litigation Reform Act of 1995. Terms such as 'anticipates,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'intends,' 'may,' 'might,' 'plan,' 'possible,' 'potential,' 'predicts,' 'project,' 'should,' 'towards,' 'would' as well as similar terms, are forward-looking in nature, but the absence of these words does not mean that a statement is not forward-looking. These forward looking statements include, but are not limited to, statements concerning use of proceeds from the offering, that the closing of offering will occur or will occur on the anticipated closing date, upcoming key milestones, planned clinical trials, and statements relating to the safety and efficacy of Calidi's therapeutic candidates in development. Any forward-looking statements contained in this discussion are based on Calidi's current expectations and beliefs concerning future developments and their potential effects and are subject to multiple risks and uncertainties that could cause actual results to differ materially and adversely from those set forth or implied in such forward-looking statements. These risks and uncertainties include, but are not limited to, the risk that Calidi is not able to raise sufficient capital to support its current and anticipated clinical trials, the risk that early results of clinical trials do not necessarily predict final results and that one or more of the clinical outcomes may materially change following more comprehensive review of the data, and as more patient data becomes available, the risk that Calidi may not receive FDA approval for some or all of its therapeutic candidates. Other risks and uncertainties are set forth in the section entitled 'Risk Factors' and 'Cautionary Note Regarding Forward-Looking Statements' in the Company's Form 10-K filed on March 31, 2025 and Form 10-Q filed on May 14, 2025. These reports may be amended or supplemented by other reports we file with the SEC from time to time. Contact:Dave GentryRedChip Companies, Inc.1-407-644-4256CLDI@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data